Jeffrey D. Abbey

CEO

US·SEC (Form 4)

Argos Therapeutics Inc

Total declarations

Company

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 12 Jan 2016 for ARGOS THERAPEUTICS INC. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

ARGOS THERAPEUTICS INC 1 purchase · last 08 Jan 2016

Jeffrey D. Abbey: trading record in brief

Jeffrey D. Abbey discloses dealings in Argos Therapeutics Inc to SEC (Form 4). Over a trading history stretching from 14 December 2015 to 8 January 2016, the count stands at 2 filings.

Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. 2016 to date brings 1 purchase and no sales.

The newest entry dates from 12 January 2016: a share grant, in Argos Therapeutics Inc. The last insider purchase was made public on 8 January 2016, 3,936 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.